National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
|
|
- Hubert Hubbard
- 5 years ago
- Views:
Transcription
1 National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides their interpretation of important findings and trends based on available national data as well as sources specific to their area, such as data from local medical examiners or poison control centers. As a local expert, the SCE is able to provide context to the national and local data presented. This SCE Narrative contains the following sections: SCS Highlights Changes in Legislation Substance Use Patterns and Trends Local Research Highlights (if available) Infectious Diseases Related to Substance Use (if available) The SCE Narratives for each of the 12 Sentinel Community Sites and detailed information about NDEWS can be found on the NDEWS website at NDEWS Maine SCS Drug Use Patterns and Trends,
2 National Drug Early Warning System (NDEWS) Maine Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2016: SCE Narrative Marcella Sorg, Ph.D. Rural Drug and Alcohol Research Program University of Maine Highlights Benzodiazepines remain a key drug category involved in drug use and abuse. Although the proportion of deaths involving benzodiazepines as a cause of death declined from 34% to 29% in 2015, the percentage of impaired drivers testing positive for benzodiazepines in 2015 (38%) was similar to 2014 (39%). Cocaine/crack abuse indicators have risen sharply after a multiyear trough. The number of deaths involving cocaine rose from 24 in 2014 to 35 in 2015, a 46% increase, and the number of impaired drivers testing positive for cocaine rose from 22 to 51, a 132% increase. All of the heroin abuse indicators, including deaths, impaired driver toxicology tests, arrests, seizures, and treatment admissions, are very high and increasing dramatically, continuing an upward trend that began in Heroin was involved in 39% of 2015 deaths, 26% of impaired drivers, 39% of Maine State Drug Enforcement Agency (MDEA) arrests, 42% of law enforcement seizures, and 26% of primary admissions. Although arrests and primary admissions for marijuana are at fairly low levels, 4% and 7%, respectively, general use remains very high. The percentage of drug-impaired drivers with cannabis positive urine is 55% and has continued to rise. MDMA indicators are very low and appear to be stable. Methamphetamine indicators continue to show mixed trends at mostly low levels. There were 3 deaths in 2015, only 3% of impaired drivers with methamphetamine-positive urine, and the treatment admissions numbered only 47. Yet, the incidence of methamphetamine small lab incidents has been rising sharply over the last several years, going from 28 in 2014 to 56 in Early 2016 indicators suggest this number may double. NDEWS Maine SCS Drug Use Patterns and Trends,
3 Indicators of illicitly produced fentanyl and its analogues, remain very high and increased in 2015, contributing to 87 (32%) deaths, up dramatically from 38 (18%) deaths in 2014 and 10 (3%) in Illicitly produced fentanyl and its analogs were present in 22% of forensic laboratory items received in Pharmaceutical opioid indicators, primarily oxycodone and methadone, are stable or declining and constituted less than half of the total deaths, 41%, in The percentage of pharmaceutical opioid-positive urinalyses among impaired drivers declined substantially to 48% in 2015 for the first time since 2009 from a multiyear plateau of about 60%. The percentage of primary treatment admissions for pharmaceutical opioids continued a multiyear decline from 37% in 2012 to 24% in Synthetic cathinone abuse is at low levels and declining trends since 2011 and There was one death in Among law enforcement seizures, both the number and variety have decreased. For example, in 2014, there were 63 law enforcement items received representing 12 substances, but in 2015, there were 40 items representing 6 substances. Changes in Legislation In response to the new surge in drug overdoses and influx of heroin and fentanyl trafficking, funding was provided by the legislature for ten new agents, which was an increase of 33%. Participation in the Maine Prescription Monitoring Program, already mandatory in Maine, was tightened by automatically registering physicians in the program. Attention and collaborative work on the overdose epidemic was highlighted by the creation of the Statewide Opiate Collaborative, organized by the U.S. Attorney s office. This group completed its work with an interdisciplinary set of recommendations covering treatment, law enforcement, and harm reduction. Substance Use Patterns and Trends BENZODIAZEPINES Benzodiazepines remain a key drug category involved in drug use and abuse. Although the proportion of deaths involving benzodiazepines as a cause of death declined from 34% to 29% in 2015, the percentage of impaired drivers testing positive for benzodiazepines in 2015 (38%) was similar to 2014 (39%). NDEWS Maine SCS Drug Use Patterns and Trends,
4 Benzodiazepines were named as a cause of death, generally in combination with other drugs and/or alcohol, in 79 (29%) of drug-induced deaths in 2015, which was down from 70 (34%) in 2014 and 63 (36%) in The proportion of benzodiazepine-induced deaths likely had increased from 20% in 2012 in part because of the changing practice standards of medical examiners, who are now encouraged to name all potentially involved drugs on the death certificate. In 2015, benzodiazepines were found in (38%) of impaired driver toxicology tests, which is similar to the 2014 percentage (39%). In 2015, benzodiazepines were found in only 1% of law enforcement items, 1 and in 1% of Maine State Drug Enforcement Agency (MDEA) arrests, the latter a substantial decrease compared with the multiyear period when the percentage was approximately 17%. The number of primary benzodiazepine treatment admissions peaked at 121 in 2011, but they declined to 91 in In 2014, they declined further to 68 in 2014, representing less than 1% of all admissions. After a change in data systems, the number of admissions in 2015 was 57, again less than 1% of admissions. COCAINE Cocaine/crack abuse indicators have risen sharply after a multiyear trough. The number of deaths involving cocaine rose from 24 in 2014 to 35 in 2015, a 46% increase, and the number of impaired drivers testing positive for cocaine rose from 22 to 51, a 132% increase. Cocaine/crack abuse indicators have risen after a multiyear trough. Deaths from cocaine have risen from only 10 statewide in 2013, to 24 in 2014, and to 35 in 2015, the latter an increase of 46%. Nine percent of impaired drivers tested positive for cocaine in both 2013 and in 2014, more than doubling to 17% in Cocaine was found in 26% of law enforcement items received for testing at the State lab in 2015, which was an increase from 21% in The National Forensic Laboratory Information System (NFLIS) correspondingly reported that cocaine was identified in 24.9% of items in After rising sharply in 2013 along with heroin, the number of arrests remained stable in 2014, at 113, but increased sharply again in 2015 to 151. Proportions of primary treatment admissions for cocaine stayed stable at 3% from 2013 to The proportion of primary admissions citing a smoking route of administration decreased to 31% in 2015 from 62% in 2014, whereas inhalation increased from 20% in 2014 to 26% in 2015, and injection remained stable at 15% in both 2014 and MARIJUANA Although arrests and primary admissions for marijuana are at fairly low levels, 4% and 7%, respectively, general use remains very high. The percentage of drug-impaired drivers with cannabis positive urine is 55% and has continued to rise. Marijuana indicators continue to show mixed levels and trends. Arrests continued to decline reaching 6% in 2014 and 4% in The percentage of drug-impaired drivers with cannabinoid-positive urine has increased since 1 Beginning with the 2015 NDEWS report, we are reporting items tested in the year they were received, rather than in the year they were tested, if those years are different. All annual lab results going back to 2010 have been recalculated for the purpose of this report to represent the year received. This provides a more current picture of drug trafficking patterns. NDEWS Maine SCS Drug Use Patterns and Trends,
5 2010, reaching 52% in 2014 and 55% in NFLIS reported that 1.7% of 1,327 items tested in 2015 were positive for cannabis, ranking 10th among drug frequencies; the percentage of items received in 2015 in this analysis was the same. Primary marijuana treatment admissions declined slightly from 8% in 2014 to 7% in The age and gender distribution of primary treatment admissions for marijuana has also remained fairly stable; in 2015, it was 73% male, 24% younger than 18, and 35% 18 to 25 years of age. METHAMPHETAMINE Methamphetamine indicators continue to show mixed trends at mostly low levels. There were 3 deaths in 2015, only 3% of impaired drivers with methamphetamine-positive urine, and the treatment admissions numbered only 47. Yet, the incidence of methamphetamine small lab incidents has been rising sharply over the last several years, going from 28 in 2014 to 56 in Early 2016 indicators suggest this number may double. Methamphetamine indicators continue at low levels and show mixed trends. Three methamphetamine deaths were identified in Among 308 drug-impaired drivers tested in 2015, 8 (3%) had a methamphetaminepositive urinalyses. The MDEA responded to 56 clandestine, small lab incidents in 2015, up from 28 in 2014, 20 in 2013 and 12 in Law enforcement indicators show a continual increase since 2012 in items received, peaking at 73 (6%) in 2014, and declining to 50 (4%) in NFLIS similarly reported 5.5% of items tested as methamphetamine in MDEA arrests for methamphetamine manufacture, trafficking or possession have risen since There were a total of 85 (12%) in 2015, up from 28 (9%) in Treatment admissions have remained stable at low levels. The number of primary methamphetamine treatment admissions plateaued in the 40s from 2010 to In 2014, the number of primary methamphetamine admissions increased to 68 but dropped to 47 in MDMA NEW PYSCHOACTIVE SUBSTANCES (OTHER THAN OPIOIDS) MDMA indicators are very low and appear to be stable. Synthetic cathinone abuse is at low levels and declining trends since 2011 and There was one death in Among law enforcement seizures, both the number and variety have decreased. For example, in 2014, there were 63 law enforcement items received representing 12 substances, but in 2015, there were 40 items representing 6 substances. MDMA indicators are very low in number. There were no MDMA or MDA deaths in Two impaired drivers out of 308 had an MDMA/MDA-positive toxicology in NFLIS reported only 3 law enforcement items tested positive for MDMA in 2015, 0.2%. There were only 18 primary MDMA treatment admissions in 2015, up slightly from 5 the year before. Synthetic Cathinones Synthetic cathinone abuse is now at low levels and shows mixed trends, having declined somewhat since 2011 and Cathinones were involved in 9% of drug arrests in 2013, 8% in 2014, and 5% in Among law enforcement seizures received for testing, the number and variety of different compounds has NDEWS Maine SCS Drug Use Patterns and Trends,
6 decreased from 63 items representing 12 substances in 2014 to 40 items representing 6 substances in 2015: Alpha-PVP (alpha-pyrrolidinopentiophenone) was the most frequently found (n = 23), followed by bk-mdea (n = 8), alpha-php (n = 4), PV8 (n = 3), and 4-fluoro-alpha-PVP and TH-PVP (each n = 1). Among 2015 treatment admissions, 26 were for a primary problem of bath salts, also described as other stimulants and other amphetamines. One death was attributed to alpha-pvp. Heroin OPIOIDS All of the heroin abuse indicators, including deaths, impaired driver toxicology tests, arrests, seizures, and treatment admissions, are very high and increasing dramatically, continuing an upward trend that began in Heroin was involved in 39% of 2015 deaths, 26% of impaired drivers, 39% of Maine State Drug Enforcement Agency (MDEA) arrests, 42% of law enforcement seizures, and 26% of primary admissions. Indicators of illicitly produced fentanyl and its analogues, remain very high and increased in 2015, contributing to 87 (32%) deaths, up dramatically from 38 (18%) deaths in 2014 and 10 (3%) in Illicitly produced fentanyl and its analogs were present in 22% of forensic laboratory items received in Pharmaceutical opioid indicators, primarily oxycodone and methadone, are stable or declining and constituted less than half of the total deaths, 41%, in The percentage of pharmaceutical opioidpositive urinalyses among impaired drivers declined substantially to 48% in 2015 for the first time since 2009 from a multiyear plateau of about 60%. The percentage of primary treatment admissions for pharmaceutical opioids continued a multiyear decline from 37% in 2012 to 24% in Heroin/morphine abuse indicators increased rather dramatically beginning in 2012 and Deaths from heroin/morphine, alone or in combination with other drugs or alcohol, decreased to 4% during 2010 and 2011 but then rose sharply starting in 2012, and doubled in 2015, now constituting 39% of deaths. Approximately one year after the upsurge in heroin deaths, an associated outbreak of deaths from non-pharmaceutical fentanyl occurred. Presumed heroin deaths are identified methodologically, including cases with literal mentions of heroin or heroin/morphine on the death certificate along with an evaluation of data from the scene and the prescription monitoring program that rules out known pharmaceuticals. Non-pharmaceutical fentanyl deaths are identified using the same approach; fentanyl analogs are combined with the overall total of non-pharmaceutical fentanyl deaths and subtotaled. Heroin/morphine-positive impaired driver urinalysis toxicology tests rose sharply from 8% in 2009 to 21% (n = 247) during 2014 and then to 26% (n = 308) in Of the 80 drivers who tested positive for heroin/morphine, 12 (15%) also tested positive for fentanyl and 18 (23%) for cocaine; 7 (9%) tested positive for both. Heroin arrests by the MDEA began increasing in 2011, and during 2015, they constituted 39% of arrests, compared with the 5% low in Arrestees are frequently from New York City and are often connected to street gangs. NFLIS reported that 32.8% of law enforcement 1,327 items tested in 2015 were positive for heroin, making it number one among all drug frequencies. We examined the percentage of law enforcement items NDEWS Maine SCS Drug Use Patterns and Trends,
7 received in , but were tested in 2015 or 2016, which was 29.6%. Of the 1,172 items received, 3.1% were positive for both heroin and fentanyl and 1.6% for heroin and acetyl fentanyl. A total of 1.5% of items were positive for both heroin and cocaine. Primary heroin admissions rose from 6% in 2010 to 22% in 2014 and to 27% in Males (56%) outnumbered females (44%) in 2015 heroin admissions, with the age group comprising 72%, which was up slightly from 67% in Other Opioids Indicators for illicitly produced fentanyl and its analogues remain very high in 2015, contributing to 87 (32%) of Maine s drug-induced deaths, up dramatically from 38 (18%) deaths in 2014 and 10 (3%) deaths in Fentanyl was known to be pharmaceutical in 6 cases in 2015, which were excluded from the number presumed to be non-pharmaceutical. Pharmaceutical opioid-induced deaths totaled 112 (41% of drug overdoses), excluding those presumed to be from non-pharmaceutical fentanyl. Among the pharmaceutical opioid deaths, the most frequent remain from oxycodone, 37 (14%), and methadone, 38 (also 14%). The WONDER data adapted for NDEWS, which extended from 2010 to 2014, differ from the data reported here in several ways. First, the medical examiner-based data include all occurrent deaths, that is, those deaths that occur in the state, whether or not the decedent was a resident; the WONDER data include all resident deaths only. Second, the medical examiner data as reported in this profile expand on the literal death certificate methodologically. In this analysis, pharmaceutical is segregated from non-pharmaceutical drugs, which affected the subtotals for fentanyl and heroin. For example, in cases where the literal cause of death is heroin/morphine, known pharmaceutical morphine has been segregated out and scene investigation data have been used to allow a presumption of heroin. In addition, although Maine medical examiners infrequently use the terms polydrug or multiple drug toxicity as a cause, without mentioning a specific drug, toxicology and autopsy data have been used here to specify the presumptive drugs involved. Thus, the data in this profile extend the literal death certificate data methodologically to enable a finer grained report of drug abuse trends. The percentage of pharmaceutical opioid-positive urinalyses among impaired drivers declined substantially in 2015 for the first time since They had been plateaued at 57% to 60% during the period and dropped to 48% in Heroin/morphine, by contrast, continued a steady increase, rising from 8% in 2009 to 26% in Pharmaceutical and illicitly produced opioids, including all forms of fentanyl, were present in 274 (22%) of forensic laboratory items received in A total of 84 (10%) were positive for fentanyl, 43 (5%) positive for acetyl fentanyl, and 14 (2%) positive for both fentanyl and acetyl fentanyl. No other fentanyl analogs were identified in 2015, and no fentanyl patches were included. Other opioids received in 2015 included 4 (0.5%) hydrocodone, 6 (0.7%) methadone, 32 (4%) buprenorphine, and 36 oxycodone. NFLIS reported that 6.9% of items received in 2015 were fentanyl, 3.9% were acetyl fentanyl, 0.4% were methadone, 0.3% hydrocodone, 2 Fentanyl patches were excluded. All items in which no drugs were found, or in which they were not ultimately tested, were removed from the denominator. NDEWS Maine SCS Drug Use Patterns and Trends,
8 0.2% hydromorphone, and 0.2% morphine. As some of these items may have contained more than one drug, they cannot be summed. The percentage of primary treatment admissions for pharmaceutical opioids rose every year for more than a decade to a peak of 37% in 2012, and they subsequently declined to 29% in 2014 and 24% in During this same time, heroin admissions remained rather stable at about 7% to 9% through 2011 and then rose to 15% in 2013, 22% in 2014, and 27% in The most common route of administration for admissions with a primary problem of pharmaceutical opioids was inhalation (41% in 2015); 19% were injecting, which was the same percentage as in Analysis of the age structure for opioid treatment admissions demonstrates that the year-old cohort has declined slightly from 22% in 2013 to 19% in 2014 and to 14% in Primary oxycodone treatment admissions constituted the most frequent single drug of the non-heroin opiate/opioid admissions, representing 48% in 2015, which was down slightly from 52% in Infectious Diseases Related to Substance Use There were 48 new HIV infections reported in 2015, which was a decrease from 58 in This represents a rate of 3.6 per 100,000 for From 2010 to 2015, 49% of new infections were attributable to male-to-male sexual contact, 4% to intravenous drug use, and 1% to male-to-male sexual contact and intravenous drug use. From 2011 to 2014, the age group made up the largest percentage of new infections; however, that fell from a high of 50% in 2011 to 33% in 2014, with a compensatory rise observed in the age group, which increased from 4% in 2011 to 16% in In 2015, though, the and age groups both made up the largest percentage of new infections at 27% each, with the age group declining slightly to 15%. There were 9 cases of acute hepatitis B in Maine during 2015, with a rate of 0.7 cases per 100,000, compared with 12 cases in There were 107 cases of probable and confirmed cases of chronic hepatitis B in 2015, with a rate of 8.1 cases per 100,000, compared with 108 cases in In 2015, the most reported risk factor for acute infection was drug use (injection 44%; noninjection 56%). There were 30 cases of acute hepatitis C in Maine during 2015, with a rate of 2.3 per 100,000. This represents a tripling of the rate from 2013 when there were 0.7 cases per 100,000. Maine has the fifth highest rate of acute hepatitis C nationwide. In 2015, there were 91 confirmed cases of chronic hepatitis C. A large spike in the number new infections in individuals younger than 30 years of age was also observed. Of 20 cases that were contacted for detailed follow-up, 15 reported use of street drugs and 11 reported intravenous drug use. NDEWS Maine SCS Drug Use Patterns and Trends,
9 Exhibits Exhibit 1. Number of Primary Admissions for Key Drugs, CY Cocaine Heroin/Morphine 1, ,058 1,386 2,035 2,691 2,780 Other Opiates 4,185 4,372 4,409 4,698 4,509 3,468 2,555 Marijuana 1,303 1,275 1,179 1,113 1, Methamphetamine Alcohol 6,481 5,904 4,726 4,473 4,453 4,068 3,583 Benzodiazepines n/a n/a n/a n/a n/a n/a 57 MDMA n/a n/a n/a n/a n/a n/a 18 Synthetic Stimulants n/a n/a n/a n/a n/a n/a 26 Synthetic Cannabinoids n/a n/a n/a n/a n/a n/a 6 Other Total Admissions 14,498 13,576 12,510 12,868 13,290 11,615 10,500 Source: Maine Office Substance Abuse and Mental Health Services NDEWS Maine SCS Drug Use Patterns and Trends,
10 Exhibit 2. Number of Arrests by the Maine Drug Enforcement Agency for Key Drug Categories, CY Cocaine/Crack Heroin Methamphetamine Marijuana Pharmaceuticals Benzodiazepines Total Arrests Source: Maine Drug Enforcement Agency NOTE: Individual drug category totals do not sum to the total number arrests because not all drug categories are included in this table. NDEWS Maine SCS Drug Use Patterns and Trends,
11 Exhibit 3. Percent of Items Seized by Law Enforcement Statewide Testing for Key Drug Categories Identified by the Maine State Health and Environmental Testing Laboratory, CY (n = 811) (n = 995) (n = 999) (n = 1,128) (n = 974) (n = 826) Cocaine Pharmaceutical Opiates* Heroin Fentanyl Powder and residues & Acetyl Fentanyl (excludes fentanyl patches) Marijuana Benzodiazepines Source: Maine Health and Environmental Testing Laboratory *Includes items with fentanyl patches, powder, or residue but not acetyl fentanyl. NDEWS Maine SCS Drug Use Patterns and Trends,
12 Exhibit 4. Number of Deaths Caused by Key Illicit Drugs Alone or in Combination with Other Drugs, CY * Heroin/Morphine Fentanyl Cocaine Methamphetamine *Deaths from known pharmaceutical products of morphine, and fentanyl have been removed from these totals. Deaths attributed to amphetamine, a possible methamphetamine metabolite, have been excluded from the methamphetamine totals, pending a reanalysis to rule out a pharmaceutical source in those cases. Source: Maine Office of Chief Medical Examiner NDEWS Maine SCS Drug Use Patterns and Trends,
13 Exhibit 5. Number of Deaths Caused by Key Pharmaceutical Opioids Alone or in Combination with Other Drugs, CY Pharmaceutical Morphine* Pharmaceutical Fentanyl** Oxycodone Methadone **Only known prescription sources are included. Source: Maine Office of Chief Medical Examiner NDEWS Maine SCS Drug Use Patterns and Trends,
14 Exhibit 6. Pharmaceutical Status of Fentanyl in CY Fentanyl-induced Deaths Fentanyl: no patch or known Rx Fentanyl: patch or Rx was identified Source: Maine Office of Chief Medical Examiner NDEWS Maine SCS Drug Use Patterns and Trends,
15 Exhibit 7. Percentage of Urine Tests of Impaired Drivers Testing Positive for Key Drugs, CY % 60% 50% 40% 30% 20% 10% 0% THC Cocaine Heroin/Morph ine One or more BZD One or more Rx Opioid % 7% 8% 40% 59% % 8% 9% 40% 59% % 9% 12% 45% 59% % 12% 11% 60% 60% % 9% 15% 40% 58% % 9% 21% 39% 57% % 17% 26% 38% 48% Source: Maine State Health and Environmental Testing Laboratory NDEWS Maine SCS Drug Use Patterns and Trends,
16 Exhibit 8. Percentage of Primary Treatment Admissions for Heroin/Morphine and for Pharmaceutical Opiates, CY % 35% 30% 25% 20% 15% 10% 5% 0% Heroin/Morphine 4% 6% 8% 7% 8% 8% 8% 7% 8% 9% 7% 8% 11% 15% 23% 27% Opiates 6% 9% 10% 11% 13% 18% 19% 22% 27% 29% 32% 35% 37% 34% 29% 24% Source: Maine Office Substance Abuse and Mental Health Services NDEWS Maine SCS Drug Use Patterns and Trends,
17 Data Sources Data for this report were drawn from the following sources: Treatment admissions data were provided by the Maine Center for Disease Control and include all admissions to programs receiving State funding. This report includes all 2015 treatment admissions, including admissions for methadone clinics, and makes comparisons with prior calendar years. In March of 2015, data were migrated to a new information system; the migrated data are still being validated, and caution is urged comparing 2015 with prior years. Totals include alcohol admissions (Exhibits 1 and 8). Mortality data were generated by analysis of State of Maine Office of Chief Medical Examiner case files for all drug-induced cases through December That office investigates all drug-related cases statewide (Exhibits 4, 5, and 6). Arrest data were provided by the Maine State Drug Enforcement Agency (MDEA), which directs eight multijurisdictional task forces covering the entire State, generating approximately 60% of all Uniform Crime Report (UCR) drug arrests statewide. Data totals include arrests for possession or trafficking, extending through the end of 2015 (Exhibit 2). Forensic laboratory data on drug seizures were provided by the Maine State Health and Environmental Testing Laboratory, which tests all samples of drugs seized by the MDEA, as well as by other police and sheriff departments. Data were updated for 2010 to 2015 changing from date tested to date received. Data were provided for 2015 (Exhibit 3). Forensic laboratory data on urinalyses of drug-impaired drivers were provided by the Maine State Health and Environmental Testing Laboratory, which tests urine samples of drivers suspected of driving under the influence of drugs. Data were provided for 2015 (Exhibit 7). Infections Disease Related to Drug Abuse. Data were provided by the MAINE Center for Disease Control for HIV/AIDS, Hepatitis B and Hepatitis C. For additional information about the drugs and drug use patterns discussed in this report, please contact Marcella H. Sorg, Ph.D., R.N., D-ABFA, Director, Rural Drug and Alcohol Research Program, Margaret Chase Smith Policy Center, University of Maine, Building 4, 5784 York Complex, Orono, ME 04469, Phone: , mhsorg@maine.edu. NDEWS Maine SCS Drug Use Patterns and Trends,
Illicit Opioid and Methamphetamine Trends in Maine
Illicit Opioid and Methamphetamine Trends in Maine Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine Objectives Provide an overview of the illicit opioid crisis in Maine, focusing
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNDEWS Sentinel Community Site Advance Report 2016: Selected Findings for Heroin, Fentanyl, and Methamphetamine
NDEWS Sentinel Community Site Advance Report 2016: Selected Findings for Heroin, Fentanyl, and Methamphetamine Heroin, fentanyl, and 12 NDEWS Sentinel Community Sites 2016 methamphetamine are drugs of
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationEXPANDED MAINE DRUG DEATH REPORT FOR 2016 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview
EXPANDED MAINE DRUG DEATH REPORT FOR 216 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine This report, funded by the Maine Office of Attorney General, provides a summary of
More informationKing County (Seattle Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018
King County (Seattle Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018 November 2018 NDEWS Coordinating Center National Drug Early Warning System (NDEWS) www.ndews.org ndews@umd.edu
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationEXPANDED MAINE DRUG DEATH REPORT FOR 2017 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine. Overview
EXPANDED MAINE DRUG DEATH REPORT FOR 2017 Marcella H. Sorg, PhD Margaret Chase Smith Policy Center University of Maine This report, funded by the Maine Office of Attorney General, provides a summary of
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationSoutheastern Florida (Miami Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018
Southeastern Florida (Miami Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018 November 2018 NDEWS Coordinating Center National Drug Early Warning System (NDEWS) www.ndews.org ndews@umd.edu
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationVIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER
VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER To promote and protect the health of all Virginians Fatal Drug Overdose Quarterly Report Edition 216.3 Publication Date: January 217 METHODS,
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCS Snapshot The SCS Snapshot is prepared by NDEWS Coordinating Center staff and contains graphics
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationSoutheastern Florida (Miami Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017
Southeastern Florida (Miami Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017 November 2017 NDEWS Coordinating Center NDEWS is funded under NIDA Cooperative Agreement DA038360 awarded
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationWayne County (Detroit Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017
Wayne County (Detroit Area) Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017 November 2017 NDEWS Coordinating Center NDEWS is funded under NIDA Cooperative Agreement DA038360 awarded to
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site Profile 2015: King County (Seattle Area)
National Drug Early Warning System (NDEWS) Sentinel Community Site Profile 2015: King County (Seattle Area) August 2015 NDEWS Coordinating Center NDEWS is funded under NIDA Cooperative Agreement DA038360
More informationDrug Threat Summaries of Designated Areas
Drug Threat Summaries of Designated Areas Oregon-Idaho HIDTA Program Oregon-Idaho HIDTA Investigative Support Center November 217 Page Intentionally Left Blank Prepared by the Oregon-Idaho Investigative
More informationLos Angeles County Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017
Los Angeles County Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017 November 2017 NDEWS Coordinating Center NDEWS is funded under NIDA Cooperative Agreement DA038360 awarded to the Center
More informationNational Drug Early Warning System (NDEWS) Los Angeles County Sentinel Community Site Appendix Data Tables, 2015
National Drug Early Warning System (NDEWS) Los Angeles County Sentinel Community Site Appendix Data Tables, 2015 NDEWS Coordinating Center Table 1: Demographic and Socio-Economic Characteristics, 2009-2013,
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationLos Angeles County Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018
Los Angeles County Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018 November 2018 NDEWS Coordinating Center National Drug Early Warning System (NDEWS) www.ndews.org ndews@umd.edu @ndewsnews
More informationMiami Dade County Substance Abuse Trends and Needs Assessment 2017
2017 HIGHLIGHTS James N. Hall, Senior Epidemiologist Center for Applied Research on Substance Use and Health Disparities Nova Southeastern University Non pharmaceutical fentanyl from foreign clandestine
More informationDenver Metro Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017
Denver Metro Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017 November 2017 NDEWS Coordinating Center NDEWS is funded under NIDA Cooperative Agreement DA038360 awarded to the Center for
More informationPalm Beach County Substance Awareness Coalition. Drug Abuse Trends In Palm Beach County, Florida Annual Report: July 2017
Drug Abuse Trends In Palm Beach County, Florida Annual Report: July 2017 TABLE OF CONTENTS SECTION I. INTRODUCTION SECTION I A. REPORT HIGHLIGHTS... 2 SECTION I B. DATA SOURCES... 3 SECTION II. PATTERNS
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationMinneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update
Minneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update Carol Falkowski Drug Abuse Dialogues ABSTRACT Heroin and other opiate addiction continued to escalate in the Twin Cities in 2013.
More information2017 Drug Use Trends in King County, Washington
May 2018 2017 Drug Use Trends in King County, Washington Contributors: Caleb Banta-Green, PhD MPH MSW, Jason Williams, PhD and the King County Community Epidemiology Workgroup Drug Specific Synopses for
More informationDrug Abuse Trends Minneapolis/St. Paul, Minnesota
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Drug Abuse Trends Minneapolis/St.
More informationNational Drug Early Warning System (NDEWS) Texas Sentinel Community Site Appendix Data Tables, 2015 NDEWS Coordinating Center
National Drug Early Warning System (NDEWS) Texas Sentinel Community Site Appendix Data Tables, 2015 NDEWS Coordinating Center Table 1: Demographic and Socio-Economic Characteristics, 2009-2013, ACS Table
More informationPhiladelphia Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018
Philadelphia Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018 November 2018 NDEWS Coordinating Center National Drug Early Warning System (NDEWS) www.ndews.org ndews@umd.edu @ndewsnews network.ndews.org
More informationMODUS OPERANDI FENTANYL. Control No.: P-693/
Control No.: P-693/09-2017 Requesting country: The United States of America File No.: 2017/202335-1 Date of publication: 13/09/2017 MODUS OPERANDI FENTANYL RISE IN USE, OVERDOSE, AND EXPOSURE TO AN OPIOID
More informationDrug Abuse Trends in Miami-Dade County Florida: June 2015
Drug Abuse Trends in Miami-Dade County Florida: June 2015 TABLE OF CONTENTS SECTION I. INTRODUCTION... 2 SECTION I A. REPORT HIGHLIGHTS... 2 SECTION I B. AREA DESCRIPTION... 3 SECTION I C. DATA SOURCES...
More informationPhiladelphia Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017
Philadelphia Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017 November 2017 NDEWS Coordinating Center NDEWS is funded under NIDA Cooperative Agreement DA038360 awarded to the Center for
More informationNational Drug Early Warning System (NDEWS) Atlanta Metro Sentinel Community Site Drug Use Patterns and Trends, 2015
National Drug Early Warning System (NDEWS) Atlanta Metro Sentinel Community Site Drug Use Patterns and Trends, 2015 Brian J. Dew, Ph.D. and Ned Golubovic, M.S. SCS Highlights Heroin use in Atlanta continues
More informationDrug Abuse Trends Minneapolis/St. Paul, Minnesota
Drug Abuse Trends Minneapolis/St. Paul, Minnesota January 28 Carol Falkowski Chemical Health Division Minnesota Department of Human Services Numerous indicators of methamphetamine (meth) abuse, particularly
More informationClaire Gilbert, Tony Margetts, Gilda Nunez, Bryony Sedgwick, Tim Allison. Thanks to Hull Public Health, Prof. Marks and Paul Smith
There is something in the heroin: responding to a rise in drug related deaths and the emergence of fentanyl and carfentanil in a local illicit drug market Claire Gilbert, Tony Margetts, Gilda Nunez, Bryony
More informationFigure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,
Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217
More informationSan Francisco Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017
San Francisco Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2017 November 2017 NDEWS Coordinating Center NDEWS is funded under NIDA Cooperative Agreement DA038360 awarded to the Center for
More informationMontgomery County Poisoning Death Review:
Wright State University CORE Scholar Unintentional Prescription Drug Poisoning Project Center for Interventions, Treatment and Addictions Research 5-6-214 Montgomery County Poisoning Death Review: 21-213
More informationAnnual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use
Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org
More informationIdentification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities
Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,
More informationLinking Opioid Treatment in Primary Care. Roxanne Lewin M.D.
Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals
More informationDrug-related hospital stays in Australia
Drug-related hospital stays in Australia 1993 2012 Prepared by Funded by Amanda Roxburgh and Lucy Burns, National Drug and Alcohol Research Centre the Australian Government Department of Health and Ageing
More informationCommunity Epidemiology Report November 2014
Community Epidemiology Report November 214 Drug Abuse Trends Update Broward County and South Florida James N. Hall, Epidemiologist Center for Applied Research on Substance Use and Health Disparities Nova
More informationMayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY TYPES OF OPIOIDS DEFINITION OF OPIOID. Pill Press from China
The Opioid Epidemic In Broward County 8/24/217 Mayors Opioid Summit PATTERNS AND TRENDS OF THE OPIOID EPIDEMIC IN BROWARD COUNTY Jim Hall Senior Epidemiologist Center for Applied Research on Substance
More informationWORLD DRUG REPORT 2011
WORLD DRUG REPORT 2011 EXECUTIVE SUMMARY Global developments in illicit drug consumption, production and trafficking Consumption Globally, UNODC estimates that, in 2009, between 149 and 272 million people,
More informationFentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar. July-16-18
Fentanyl and Synthetic Opioids- Awareness and the Enforcement Pillar Opioid Situation-How we got here 2012 Oxycontin moves to the tamper proof version OxyNeo (Purdue Pharma) 2012/2013 Patch diversion and
More informationMontgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016
Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Prepared by: Robert G. Carlson, Ph.D., Professor and Director, Project Director Linna Li, M.S., Data Manager Raminta Daniulaityte,
More informationOpiate/opioid-Related Deaths in New Hampshire. Thomas A. Andrew, MD Chief Medical Examiner State of New Hampshire
Opiate/opioid-Related Deaths in New Hampshire Thomas A. Andrew, MD Chief Medical Examiner State of New Hampshire A National Public Health Issue Since 2000 drug deaths increased 137% 200% increase in opioids
More informationA Preliminary Report on Trends and Impact. Mike McGrath. January Montana Attorney General
Methamphetamine in Montana A Preliminary Report on Trends and Impact January 2007 Mike McGrath Montana Attorney General 1 Methamphetamine in Montana A Preliminary Report on Trends and Impact January 2007
More informationNational Institute on Drug Abuse
National Institute on Drug Abuse Community Epidemiology Work Group (CEWG) NIDA Community Epidemiology Work Group 62 nd Semi- Annual Meeting June 2007 Seattle Honolulu Jim Hall Center for the Study and
More informationOHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS
OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements found in the opium poppy plant. These drugs are
More informationNational Drug Early Warning System (NDEWS): A New Approach for Multi-Level Monitoring of Opioid Trends in the U.S.
National Drug Early Warning System (NDEWS): A New Approach for Multi-Level Monitoring of Opioid Trends in the U.S. Presented by E. Erin Artigiani, MA Moira O Brien, MPH, NIDA Project Scientist; Eric D.
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14
More informationEnd the Epidemic. Miami-Dade County COMPREHENSIVE COMMUNITY PREVENTION ACTION PLAN
End the Epidemic Miami-Dade County COMPREHENSIVE COMMUNITY PREVENTION ACTION PLAN 2018 2021 Miami-Dade County along with the State of Florida and the Nation are dramatically impacted by an Opioid Epidemic
More informationDrug Trends and Trafficking in Montana and Beyond
Drug Trends and Trafficking in Montana and Beyond DRUG ENFORCEMENT ADMINISTRATION Travis Birney Special Agent Billings Resident Office Travis.C.Birney@usdoj.gov Office: 406-655-2914 Cell: 406-208-9242
More informationWorkforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics Analysis
News from Quest Diagnostics Media: Kim Gorode, 973.520.2800 Investors: Shawn Bevec, 973.520.2900 Workforce Drug Testing Positivity Climbs to Highest Rate Since 2004, According to New Quest Diagnostics
More informationFlorida Drug Trends 2017
Florida Drug Trends 217 Lee A. Crandall, Ph.D., Professor Department of Public Health Sciences Clemson University This product is supported by Florida Department of Children and Families Substance Abuse
More informationUnited Way of Broward County Commission on Substance Abuse. Drug Abuse Trends in Broward County, Florida: June 2014
United Way of Broward County Commission on Substance Abuse Drug Abuse Trends in Broward County, Florida: June 2014 Drug Abuse Trends in Broward County, Florida: June 2014 James N. Hall 1 ABSTRACT The key
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 2008
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: SECOND QUARTER, 28 A report from the Office of Epidemiology and Planning Baltimore City Health Department
More informationDrug related hospital stays in Australia
Prepared by Funded by Amanda Roxburgh and Courtney Breen, National Drug and Alcohol Research Centre the Australian Government Department of Health Recommended Roxburgh, A. and Breen, C (217). Drug-related
More informationDrug-related hospital stays in Australia
Drug-related hospital stays in Australia 1993-213 Prepared by Amanda Roxburgh and Lucinda Burns, National Drug and Alcohol Research Centre Funded by the Australian Government Department of Health Introduction
More informationWorkforce Drug Positivity at Highest Rate in a Decade, Finds Analysis of More Than 10 Million Drug Test Results
Contacts: Kim Gorode, Quest Diagnostics (Media): 973-520-2800 Shawn Bevec, Quest Diagnostics (Investors): 973-520-2900 News from Quest Diagnostics Workforce Drug Positivity at Highest Rate in a Decade,
More informationNational Drug Early Warning System (NDEWS) Denver Metro Sentinel Community Site Drug Use Patterns and Trends, 2015
National Drug Early Warning System (NDEWS) Denver Metro Sentinel Community Site Drug Use Patterns and Trends, 215 Bruce Mendelson, MPA SCS Highlights Alcohol ranks as the number one drug of abuse in the
More informationComparing Accidental Drug Overdose Trends in Montgomery and 23 Other Ohio Counties: 2010 June 2013
Comparing Accidental Drug Overdose Trends in Montgomery and 23 Other Ohio Counties: 21 June 213 Raminta Daniulaityte, Ph.D., Co-I Timothy Lane, M.Ed., Co-I Robert G. Carlson, Ph.D., PI Center for Interventions,
More information60 Y BC DOAP REPORT 2014
BC DOAP REPORT 214 MORTALIT The BC Vital Statistics Agency is responsible for the ascertainment, registration and certification of vital events. It identifies the causes of death according to the World
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site Profile 2015: New York City
National Drug Early Warning System (NDEWS) Sentinel Community Site Profile 2015: New York City August 2015 NDEWS Coordinating Center NDEWS is funded under NIDA Cooperative Agreement DA038360 awarded to
More informationPoisoning Death Review Report. Montgomery County, 2017
Poisoning Death Review Report Public Health Dayton & Montgomery County Prepared by Epidemiology Section Published May 15, 2018 Page 2 of 53 Contents Executive Summary... 5 Number of Drug Overdose... 5
More informationReport on Drugged Driving in Louisiana. Quantification of its Impact on Public Health and Implications for Legislation, Enforcement and Prosecution
Report on Drugged Driving in Louisiana Quantification of its Impact on Public Health and Implications for Legislation, Enforcement and Prosecution Objectives Objective 1: Evaluate laws and policies about
More informationAnnual report 2012: the state of the drugs problem in Europe
Annual report 2012: the state of the drugs problem in Europe Ilze Jekabsone, MD, MPH Reitox and international cooperation unit 14 December 2012 2 Setting the scene After 30+ years with heroin centre stage
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationOpioid Overdose in Oregon Report to the Legislature
SEPTEMBER 2018 Opioid Overdose in Oregon Report to the Legislature This report summarizes the burden of opioid overdose among Oregonians as required by ORS 432.141. It describes Oregon s progress in reducing
More informationPrescription Drug Abuse Task Force Rx Report Card
San Diego County Prescription Drug Abuse Task Force 2016 Rx Report Card October 2016 Key Measures of Prescription Drug and Heroin Problems in San Diego County. Visit www.sandiegorxabusetaskforce.org for
More informationDRUG OVERDOSE DEATHS ANALYSIS
Overview CUYAHOGA COUNTY MEDICAL EXAMINER DRUG OVERDOSE DEATHS ANALYSIS Analysis of Fentanyl-Related Overdose Deaths in Cleveland/Cuyahoga County, Ohio in 2014 April 2015 The Cuyahoga County Medical Examiner
More informationDrug Trends &Trafficking I/S Brian Dempsey
Drug Trends &Trafficking I/S Brian Dempsey 412-777-6945 brian.w.dempsey@usdoj.gov Sources Sources 360 Degree Strategy Strategic collaboration and guidance via three interconnected avenues. Community
More informationTesting for Controlled Substances
Testing for illicit drugs Testing for Controlled Substances 1 Purposes: Employment Sports Screening medical eval. Legal Monitoring Treatment Probation Prescribing controlled substances Forensics 2 Drug
More informationTexas Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018
Texas Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018 November 2018 NDEWS Coordinating Center National Drug Early Warning System (NDEWS) www.ndews.org ndews@umd.edu @ndewsnews network.ndews.org
More informationTOWARD A REAL-TIME DRUG OVERDOSE MONITORING SYSTEM
TOWARD A REAL-TIME DRUG OVERDOSE MONITORING SYSTEM Using Locally Available Data Richard Harruff, MD, PhD Chief Medical Examiner Julia Hood, PhD, MPH Epidemiologist Goals for Today s Presentation 1. Make
More informationAtlanta Metro Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018
Atlanta Metro Sentinel Community Site (SCS) Drug Use Patterns and Trends, 2018 November 2018 NDEWS Coordinating Center National Drug Early Warning System (NDEWS) www.ndews.org ndews@umd.edu @ndewsnews
More informationNational Drug-Related Deaths Index
HRB Bulletin Drug Deaths 2015 National Drug-Related Deaths Index 2004 to 2015 data Overview This update presents figures from the National Drug- Related Deaths Index (NDRDI) on deaths due to poisoning
More informationDrug Abuse Trends in Minneapolis/St. Paul, Minnesota: June 2012
Drug Abuse Trends in Minneapolis/St. Paul, Minnesota: June 2012 Carol L. Falkowski Drug Abuse Strategy Officer Minnesota Department of Human Services June 2012 ABSTRACT Escalating trends regarding the
More information2007 ANNUAL REPORT. January 1, 2007 to December 31, 2007 James N. Hall Madeline Camejo, MS, Pharm.D.
2007 ANNUAL REPORT January 1, 2007 to December 31, 2007 James N. Hall Madeline Camejo, MS, Pharm.D. United Way of Broward County Commission On Substance Abuse Miramar Police Department Circuit 17, FL Dept.
More informationConflict of Interest Disclosure
Patient Rx Drug Misuse and Abuse: Compliance Toxicology Monitoring in Clinical Practice Toxicology Staff Andrea Terrell, Ph.D., DABCC Chief Scientific Officer George Behonick, Ph.D., DABFT, Manager, FBU
More informationPinellas County Forensic Laboratory. Annual Report 2006
Pinellas County Forensic Laboratory Annual Report 26 Published April 27 Analytical Services Provided Post Mortem/Medical Examiner Toxicology Seized Drug (Controlled Substances) Analysis Fire Debris and
More information[ ASSESSING THE BURDEN OF ILLICIT DRUGS AND ALCOHOL ABUSE:] Macomb County Office of Substance Abuse. A Focus on Heroin and Prescription Drug Abuse
2010 Macomb County Office of Substance Abuse Planning Contracting Monitoring [ ASSESSING THE BURDEN OF ILLICIT DRUGS AND ALCOHOL ABUSE:] A Focus on Heroin and Prescription Drug Abuse 22550 Hall Road Clinton
More informationEarlier arrests among apprehended drivers in Norway with heroin and ecstasy detection
Earlier arrests among apprehended drivers in Norway with heroin and ecstasy detection A. S. Christophersen¹, A. M. Hausken¹ and S. Skurtveit¹ ² ¹National Institute of Forensic Toxicology, P.O. Box 495
More informationReducing Opioid Deaths: Arizona s Emergency Declaration & Response
Reducing Opioid Deaths: Arizona s Emergency Declaration & Response September 15, 2017 Sheila Sjolander, Assistant Director Arizona Department of Health Services Emergency Declaration On June 5, 2017, Arizona
More informationOrange County Heroin Task Force
Orange County Heroin Task Force Heroin-Related Data Summary AGENDA (Proposed) Orange County Heroin Task Force: On August 17, 2015, Mayor Teresa Jacobs convened the Orange County Heroin Task Force and asked
More informationThe South Florida Report June 2013
Escambia Santa Rosa Okaloosa Holmes Bay Jacks on Calhoun Gulf Liberty Gadsden Leon Franklin Wakulla Madison Taylor Dixie Hamilton Suwannee Union Gilchrist Alachua Pinellas Levy Citrus Baker Hernando Pasco
More informationIllicit Drug Positivity Rate Increases Sharply in Workplace Testing, Finds Quest Diagnostics Drug Testing Index Analysis
News from Quest Diagnostics Contacts: Wendy Bost, Quest Diagnostics (Media): 973-520-2800 Dan Haemmerle, Quest Diagnostics (Investors): 973-520-2900 Illicit Drug Positivity Rate Increases Sharply in Workplace
More information